FDA approves Wegovy for cardiovascular risk reduction in overweight patients.

The FDA has approved the use of obesity drug Wegovy to reduce the risk of stroke, heart attacks, and other serious cardiovascular problems in overweight patients. Wegovy, which has already helped millions of Americans shed pounds, can now be used for those with cardiovascular disease and either obesity or overweight. This marks the first approval of its kind, significantly expanding the market for the drug.